Evaluation of Serum hs-CRP Levels in Patients with Helicobacter pylori Infection Confirmed by Non-Invasive Tests
- 1Al-Muthanna University
Abstract
Background and Aim: Diagnosing Helicobacter pylori infection non-invasively remains a challenge, and upper endoscopy is often relied upon unnecessarily. This study aimed to assess the diagnostic accuracy of combining high-sensitivity C-reactive protein (hs-CRP) with a standard non-invasive test, the urea breath test (UBT), and to compare the results with the stool antigen (Stool Ag) test, in order to improve diagnostic accuracy and reliability and to reduce dependence on diagnostic upper endoscopy.
Methods: The study included 150 patients with dyspeptic symptoms (89 males, 59.3%; 61 females, 40.7%), with a mean age of 34.19 years. Statistical analyses were performed using IBM SPSS Statistics and included Welch’s t-test, Fisher’s exact test, and ROC analysis to determine diagnostic performance and optimal cut-off points. UBT was used as the validated reference standard against which hs-CRP and the Stool Ag test were compared.
Results: UBT showed a positivity rate of 98%. Mean hs-CRP was significantly higher in the positive group (67.52 ± 38.11 mg/L) than in the negative group (0.96 ± 0.81 mg/L; p < 0.001, Welch’s t-test). On ROC analysis, hs-CRP yielded an AUC of 1.000, indicating optimal predictive performance at a threshold of >10 mg/L, with 97.28% sensitivity and 100% specificity. The kappa value of 0.588 indicated moderate agreement between the diagnostic methods used.
Conclusion: Although hs-CRP is a broad indicator of systemic inflammation rather than a pathogen-specific diagnostic test, its evaluation alongside UBT may reflect the magnitude of the associated inflammatory response in symptomatic patients.
Related
- Conservative Infection Prevention and Control Practices in a Patient With Confirmed Creutzfeldt-Jakob Disease.
- Helicobacter pylori Infection Remodels Neutrophil‐Derived Extracellular Vesicles, Promoting Stress and Apoptosis in Infected Epithelial Cells
- Clinical and laboratory determinants of treatment response and rifampicin resistance among Xpert MTB/RIF-confirmed extrapulmonary tuberculosis patients: A prospective study from Central India
- Platelet miRNA-Based Signature as a Potential Non-Invasive Tool for Discriminating Patients with Secondary Progressive Multiple Sclerosis from Healthy Individuals
- Crystal structure of tyrosine-tRNA synthetase from Helicobacter pylori G27
BibTeX
@article{alhamadani2026evaluation,
title = {{Evaluation of Serum hs-CRP Levels in Patients with Helicobacter pylori Infection Confirmed by Non-Invasive Tests}},
author = {Yousif Alhamadani},
journal = {Archives of Advances in Biosciences},
year = {2026},
month = nov,
doi = {10.22037/aab.v17i1.53277},
url = {https://doi.org/10.22037/aab.v17i1.53277},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Evaluation of Serum hs-CRP Levels in Patients with Helicobacter pylori Infection Confirmed by Non-Invasive Tests
AU - Yousif Alhamadani
PY - 2026
DA - 2026/11/16
JO - Archives of Advances in Biosciences
DO - 10.22037/aab.v17i1.53277
UR - https://doi.org/10.22037/aab.v17i1.53277
AB - Background and Aim: Diagnosing Helicobacter pylori infection non-invasively remains a challenge, and upper endoscopy is often relied upon unnecessarily. This study aimed to assess the diagnostic accuracy of combining high-sensitivity C-reactive protein (hs-CRP) with a standard non-invasive test, the urea breath test (UBT), and to compare the results with the stool antigen (Stool Ag) test, in order to improve diagnostic accuracy and reliability and to reduce dependence on diagnostic upper endoscopy. Methods: The study included 150 patients with dyspeptic symptoms (89 males, 59.3%; 61 females, 40.7%), with a mean age of 34.19 years. Statistical analyses were performed using IBM SPSS Statistics and included Welch’s t-test, Fisher’s exact test, and ROC analysis to determine diagnostic performance and optimal cut-off points. UBT was used as the validated reference standard against which hs-CRP and the Stool Ag test were compared. Results: UBT showed a positivity rate of 98%. Mean hs-CRP was significantly higher in the positive group (67.52 ± 38.11 mg/L) than in the negative group (0.96 ± 0.81 mg/L; p < 0.001, Welch’s t-test). On ROC analysis, hs-CRP yielded an AUC of 1.000, indicating optimal predictive performance at a threshold of >10 mg/L, with 97.28% sensitivity and 100% specificity. The kappa value of 0.588 indicated moderate agreement between the diagnostic methods used. Conclusion: Although hs-CRP is a broad indicator of systemic inflammation rather than a pathogen-specific diagnostic test, its evaluation alongside UBT may reflect the magnitude of the associated inflammatory response in symptomatic patients.
SN - 2783-1264
ER -